These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 26924758)

  • 1. Canine models of inherited bleeding disorders in the development of coagulation assays, novel protein replacement and gene therapies.
    Nichols TC; Hough C; Agersø H; Ezban M; Lillicrap D
    J Thromb Haemost; 2016 May; 14(5):894-905. PubMed ID: 26924758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein replacement therapy and gene transfer in canine models of hemophilia A, hemophilia B, von willebrand disease, and factor VII deficiency.
    Nichols TC; Dillow AM; Franck HW; Merricks EP; Raymer RA; Bellinger DA; Arruda VR; High KA
    ILAR J; 2009; 50(2):144-67. PubMed ID: 19293459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Animal models of hemophilia and related bleeding disorders.
    Lozier JN; Nichols TC
    Semin Hematol; 2013 Apr; 50(2):175-84. PubMed ID: 23956467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Congenital bleeding disorders.
    Rick ME; Walsh CE; Key NS
    Hematology Am Soc Hematol Educ Program; 2003; ():559-74. PubMed ID: 14633799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inherited bleeding disorders.
    Blanchette VS; Sparling C; Turner C
    Baillieres Clin Haematol; 1991 Apr; 4(2):291-332. PubMed ID: 1912663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances toward gene therapy for hemophilia at the millennium.
    Kaufman RJ
    Hum Gene Ther; 1999 Sep; 10(13):2091-107. PubMed ID: 10498242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Animal models of hemophilia.
    Sabatino DE; Nichols TC; Merricks E; Bellinger DA; Herzog RW; Monahan PE
    Prog Mol Biol Transl Sci; 2012; 105():151-209. PubMed ID: 22137432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of recombinant factor VIIa on the hemostatic defect in dogs with hemophilia A, hemophilia B, and von Willebrand disease.
    Brinkhous KM; Hedner U; Garris JB; Diness V; Read MS
    Proc Natl Acad Sci U S A; 1989 Feb; 86(4):1382-6. PubMed ID: 2784006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemophilia and von Willebrand's disease: 2. Management. Association of Hemophilia Clinic Directors of Canada.
    CMAJ; 1995 Jul; 153(2):147-57. PubMed ID: 7600466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inherited Bleeding Disorders in the Obstetric Patient.
    Bannow BS; Konkle BA
    Transfus Med Rev; 2018 Oct; 32(4):237-243. PubMed ID: 30097224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ARFI ultrasound monitoring of hemorrhage and hemostasis in vivo in canine von Willebrand disease and hemophilia.
    Scola MR; Nichols TC; Zhu H; Caughey MC; Merricks EP; Raymer RA; Margaritis P; High KA; Gallippi CM
    Ultrasound Med Biol; 2011 Dec; 37(12):2126-32. PubMed ID: 22033127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Theodore E. Woodward Award. AAV-mediated gene transfer for hemophilia.
    High KA
    Trans Am Clin Climatol Assoc; 2003; 114():337-51; discussion 351-2. PubMed ID: 12813929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New technologies in gene therapy for inducing immune tolerance in hemophilia A.
    Borsotti C; Follenzi A
    Expert Rev Clin Immunol; 2018 Dec; 14(12):1013-1019. PubMed ID: 30345839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B Cell Depletion Eliminates FVIII Memory B Cells and Enhances AAV8-coF8 Immune Tolerance Induction When Combined With Rapamycin.
    Biswas M; Palaschak B; Kumar SRP; Rana J; Markusic DM
    Front Immunol; 2020; 11():1293. PubMed ID: 32670285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene Therapy for Inherited Bleeding Disorders.
    Arruda VR; Weber J; Samelson-Jones BJ
    Semin Thromb Hemost; 2021 Mar; 47(2):161-173. PubMed ID: 33636747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic factor VIII levels and negligible toxicity in mouse and dog models of hemophilia A following gene therapy with high-capacity adenoviral vectors.
    Chuah MK; Schiedner G; Thorrez L; Brown B; Johnston M; Gillijns V; Hertel S; Van Rooijen N; Lillicrap D; Collen D; VandenDriessche T; Kochanek S
    Blood; 2003 Mar; 101(5):1734-43. PubMed ID: 12406898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Buccal mucosa bleeding time is prolonged in canine models of primary hemostatic disorders.
    Brooks M; Catalfamo J
    Thromb Haemost; 1993 Nov; 70(5):777-80. PubMed ID: 8128434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inherited abnormalities of coagulation: hemophilia, von Willebrand disease, and beyond.
    Kumar R; Carcao M
    Pediatr Clin North Am; 2013 Dec; 60(6):1419-41. PubMed ID: 24237980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of fresh-frozen plasma and cryoprecipitate in dogs with von Willebrand's disease or hemophilia A.
    Stokol T; Parry B
    J Vet Intern Med; 1998; 12(2):84-92. PubMed ID: 9560764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel therapeutics for hemophilia and other bleeding disorders.
    Callaghan MU; Sidonio R; Pipe SW
    Blood; 2018 Jul; 132(1):23-30. PubMed ID: 29769259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.